SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-040868
Filing Date
2021-08-04
Accepted
2021-08-04 16:31:44
Documents
74
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q adpt-10q_20210630.htm   iXBRL 10-Q 2733221
2 EX-31.1 adpt-ex311_81.htm EX-31.1 27596
3 EX-31.2 adpt-ex312_82.htm EX-31.2 28957
4 EX-32.1 adpt-ex321_80.htm EX-32.1 12140
5 EX-32.2 adpt-ex322_79.htm EX-32.2 13519
  Complete submission text file 0001564590-21-040868.txt   9233263

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA adpt-20210630.xsd EX-101.SCH 56280
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE adpt-20210630_cal.xml EX-101.CAL 52695
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE adpt-20210630_def.xml EX-101.DEF 199491
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE adpt-20210630_lab.xml EX-101.LAB 431454
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE adpt-20210630_pre.xml EX-101.PRE 350603
11 EXTRACTED XBRL INSTANCE DOCUMENT adpt-10q_20210630_htm.xml XML 1799444
Mailing Address 1551 EASTLAKE AVENUE EAST SUITE 200 SEATTLE WA 98102
Business Address 1551 EASTLAKE AVENUE EAST SUITE 200 SEATTLE WA 98102 206-659-0067
Adaptive Biotechnologies Corp (Filer) CIK: 0001478320 (see all company filings)

IRS No.: 270907024 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38957 | Film No.: 211144483
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences